Cargando…
Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
BACKGROUND: Coronavirus disease 2019 (COVID‐19) convalescent individuals carry antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that, through a plasma donation, can be used as a potential therapeutic either in direct transfusion or for the manufacture of hyperimmune gl...
Autores principales: | Karbiener, Michael, Farcet, Maria R., Ilk, Reinhard, Schreiner, Jessica, Lenart, James, Powers, Nicholas, Stewart, Joseph M., Tallman, Hema, Kreil, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013317/ https://www.ncbi.nlm.nih.gov/pubmed/33615484 http://dx.doi.org/10.1111/trf.16291 |
Ejemplares similares
-
Detection of Babesia
RNA and DNA in whole blood samples from US blood donations
por: Stanley, Jean, et al.
Publicado: (2021) -
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020) -
Duplex nucleic acid test for the detection of chikungunya and dengue RNA viruses in blood donations
por: Stramer, Susan L., et al.
Publicado: (2019) -
Evaluation of a new West Nile virus nucleic acid test for screening of blood donations
por: Stanley, Jean, et al.
Publicado: (2018) -
A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)